| Scrip Code | 500201 |
|---|---|
| NSE Symbol | INDIAGLYCO |
| MSEI Symbol | NOTLISTED |
| ISIN | INE560A01023 |
| Name of company | INDIA GLYCOLS LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 13-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 06-11-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 13-11-2026 16:18:00 |
| End date and time of board meeting | 13-11-2026 17:15:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 36,242.00 | 71,950.00 | |
| Other income | 33.00 | 70.00 | |
| Total income | 36,275.00 | 72,020.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 17,247.00 | 41,791.00 |
| (b) | Purchases of stock-in-trade | 365.00 | 576.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 5,341.00 | 3,494.00 |
| (d) | Employee benefit expense | 1,695.00 | 3,650.00 |
| (e) | Finance costs | 1,207.00 | 2,371.00 |
| (f) | Depreciation, depletion and amortisation expense | 1,201.00 | 2,405.00 |
| (f) | Other Expenses | ||
| 1 | Power and Fuel | 4,433.00 | 8,455.00 |
| 2 | Other Expenses | 3,280.00 | 6,154.00 |
| Total other expenses | 7,713.00 | 14,609.00 | |
| Total expenses | 34,769.00 | 68,896.00 | |
| 3 | Total profit before exceptional items and tax | 1,506.00 | 3,124.00 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 1,506.00 | 3,124.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 189.00 | 402.00 |
| 8 | Deferred tax | 212.00 | 418.00 |
| 9 | Total tax expenses | 401.00 | 820.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 1,105.00 | 2,304.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 1,264.00 | 3,324.00 |
| 16 | Total profit (loss) for period | 2,369.00 | 5,628.00 |
| 17 | Other comprehensive income net of taxes | 4.00 | (3.00) |
| 18 | Total Comprehensive Income for the period | 2,373.00 | 5,625.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 2,369.00 | 5,628.00 | |
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 11.00 | (3.00) | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 2,380.00 | 5,625.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 3,351.00 | 3,351.00 | |
| Face value of equity share capital | 5 | 5 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 3.53 | 8.4 | |
| Diluted earnings (loss) per share from continuing operations | 3.53 | 8.4 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 3.53 | 8.4 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 3.53 | 8.4 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Note on Cash Flow Statement: (1) Since there is no option to fill ‘adjustment for (Profit)/Loss on Sale of Property, plant & equipment’ and ‘Provision No Longer Required Written Back’ in the utility, the same are shown in 'Other adjustment for non-cash items'. The actual figures (Rs. in crore) are as follows: (a) Adjustment for (Profit)/Loss on Sale of Property, plant & equipment: -0.01 (b) Provision No Longer Required Written Back: -0.71 Clarification on Cash flow statement: The amount written in ‘Adjustment for decrease (increase) in trade receivables, current’ includes trade and other receivables and represents both current as well non-current part. The amount written in ‘Adjustment for decrease (increase) in trade payables, current’ includes trade and other payables and represents both current as well non-current part. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 1,25,443.00 | |
| Capital work-in-progress | 11,352.00 | |
| Investment property | 170.00 | |
| Goodwill | 0.00 | |
| Other intangible assets | 68.00 | |
| Intangible assets under development | ||
| Biological assets other than bearer plants | ||
| Investments accounted for using equity method | ||
| Non-current financial assets | ||
| Non-current investments | 42,217.00 | |
| Trade receivables, non-current | ||
| Loans, non-current | 118.00 | |
| Other non-current financial assets | ||
| 1 | Other non-current financial assets | 269.00 |
| 2 | other | 3,583.00 |
| Total of other non-current financial assets | 3,852.00 | |
| Total non-current financial assets | 46,187.00 | |
| Deferred tax assets (net) | ||
| Other non-current assets | ||
| Total of other non-current assets | ||
| Total non-current assets | 1,83,220.00 | |
| 2 | Current assets | |
| Inventories | 55,370.00 | |
| Current financial asset | ||
| Current investments | 0.00 | |
| Trade receivables, current | 7,622.00 | |
| Cash and cash equivalents | 649.00 | |
| Bank balance other than cash and cash equivalents | 878.00 | |
| Loans, current | 0.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 4,088.00 | |
| Total current financial assets | 13,237.00 | |
| Current tax assets (net) | 1,851.00 | |
| Other current assets | ||
| 1 | Other current assets | 7,424.00 |
| Total of other current assets | 7,424.00 | |
| Total current assets | 77,882.00 | |
| 3 | Non-current assets classified as held for sale | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | |
| Total assets | 2,61,102.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 3,351.00 | |
| Other equity | 1,22,427.00 | |
| Total equity attributable to owners of parent | 1,25,778.00 | |
| Non controlling interest | ||
| Total equity | 1,25,778.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 34,148.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | ||
| Total Trade payable | ||
| Other non-current financial liabilities | ||
| Total of other non-current financial liabilities | ||
| Total non-current financial liabilities | 34,148.00 | |
| Provisions, non-current | 291.00 | |
| Deferred tax liabilities (net) | 15,117.00 | |
| Deferred government grants, Non-current | ||
| Other non-current liabilities | ||
| Total of other non-current liabilities | ||
| Total non-current liabilities | 49,556.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 48,449.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 5,534.00 | |
| Total Trade payable | 5,534.00 | |
| Other current financial liabilities | ||
| 1 | Other current financial liabilities | 27,616.00 |
| Total of other current financial liabilities | 27,616.00 | |
| Total current financial liabilities | 81,599.00 | |
| Other current liabilities | 3,728.00 | |
| 1 | Other current liabilities | 3,728.00 |
| Total of other current liabilities | 3,728.00 | |
| Provisions, current | 441.00 | |
| Current tax liabilities (Net) | ||
| Deferred government grants, Current | ||
| Total current liabilities | 85,768.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | |
| Total liabilities | 1,35,324.00 | |
| Total equity and liabilites | 2,61,102.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Bio-based Specialities and Performance Chemicals | 36,242.00 | 71,950.00 | ||||
| 2 | Potable Spirits | 0.00 | 0.00 | ||||
| 3 | Ennature Biopharma | 0.00 | 0.00 | ||||
| 4 | Bio-Fuel | 0.00 | 0.00 | ||||
| Total Segment Revenue | 36,242.00 | 71,950.00 | |||||
| Less: Inter segment revenue | 0.00 | 0.00 | |||||
| Revenue from operations | 36,242.00 | 71,950.00 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Bio-based Specialities and Performance Chemicals | 2,713.00 | 5,495.00 | ||||
| 2 | Potable Spirits | 0.00 | 0.00 | ||||
| 3 | Ennature Biopharma | 0.00 | 0.00 | ||||
| 4 | Bio-Fuel | 0.00 | 0.00 | ||||
| Total Profit before tax | 2,713.00 | 5,495.00 | |||||
| i. Finance cost | 1,207.00 | 2,371.00 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 0.00 | 0.00 | |||||
| Profit before tax | 1,506.00 | 3,124.00 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Bio-based Specialities and Performance Chemicals | 2,61,102.00 | 2,61,102.00 | ||||
| 2 | Potable Spirits | 0.00 | 0.00 | ||||
| 3 | Ennature Biopharma | 0.00 | 0.00 | ||||
| 4 | Bio-Fuel | 0.00 | 0.00 | ||||
| Total Segment Asset | 2,61,102.00 | 2,61,102.00 | |||||
| Un-allocable Assets | 0.00 | 0.00 | |||||
| Net Segment Asset | 2,61,102.00 | 2,61,102.00 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Bio-based Specialities and Performance Chemicals | 1,35,324.00 | 1,35,324.00 | ||||
| 2 | Potable Spirits | 0.00 | 0.00 | ||||
| 3 | Ennature Biopharma | 0.00 | 0.00 | ||||
| 4 | Bio-Fuel | 0.00 | 0.00 | ||||
| Total Segment Liabilities | 1,35,324.00 | 1,35,324.00 | |||||
| Un-allocable Liabilities | 0.00 | 0.00 | |||||
| Net Segment Liabilities | 1,35,324.00 | 1,35,324.00 | |||||
| Disclosure of notes on segments | Textual Information(2) | ||||||
| Textual Information(2) | Share of Profit and loss of JV is clubbed with Unallocated corporate expences. |
|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Items that will not be reclassified to Profit or Loss | 1.00 | (9.00) |
| Total Amount of items that will not be reclassified to profit and loss | 1.00 | (9.00) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0.00 | (2.00) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | (3.00) | (4.00) |
| 5 | Total Other comprehensive income | 4.00 | (3.00) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | ||||
| B | Date of end of reporting period | 30-09-2026 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 3,124.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 2,371.00 | |||||
| Adjustments for decrease (increase) in inventories | 5,186.00 | |||||
| Adjustments for decrease (increase) in trade receivables, current | (444.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | 0.00 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (7,238.00) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 2,405.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 0.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (70.00) | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 286.00 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | (72.00) | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 1,852.00 | |||||
| Net cash flows from (used in) operations | 4,976.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 1,045.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 3,931.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 0.00 | |||||
| Purchase of property, plant and equipment | 9,523.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 70.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) investing activities | (9,453.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 5,826.00 | |||||
| Repayments of borrowings | 0.00 | |||||
| Payments of lease liabilities | 0.00 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 2,371.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | 3,455.00 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (2,067.00) | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | (2,067.00) | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 2,716.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 649.00 | |||||